Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Shaare Zedek Medical Center |
---|---|
Information provided by: | Shaare Zedek Medical Center |
ClinicalTrials.gov Identifier: | NCT00307918 |
Glaucoma is the leading cause of irreversible blindness in the world, resulting from progressive axonal destruction of the optic nerve. Primary open-angle glaucoma is the most common form, and it is usually painless with insidious onset. Conventional treatment is focused on lowering intraocular pressure (IOP), the one risk factor that can be modified, which has been demonstrated to protect against further damage to the optic-nerve head. Acupuncture is an ancient treatment which has been found to be beneficial for many ailments, and may reduce IOP. We propose a pilot study to evaluate whether acupuncture is an effective and safe modality for reducing elevated IOP in patients with open angle glaucoma and primary ocular hypertension. Patients with elevated IOP on tonometric measurement (20mmHg < IOP < 30mmHg) will be treated twice-weekly with a standardized (as opposed to individualized) acupuncture treatment. Treatment will last for four-weeks (for a total of 8 treatments), and patients will be evaluated for IOP diurnal curves at 2 weeks (4 treatment), 4 weeks (end of treatment ) and then 4 weeks following the last treatment.
Condition | Intervention | Phase |
---|---|---|
Elevated Intraocular Pressure |
Device: acupuncture |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Official Title: | Acupuncture Treatment for Elevated Intraocular Pressure: A Pilot Study |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
patients of either gender; age 21 years and older; intraocular pressure equal/greater than 20mmHg, equal/less than 30mmHg; ability to comply with study protocol
Exclusion Criteria:
patients with secondary or closed-angle glaucoma; patients with a history of laser or other surgical treatment of glaucoma; patients displaying symptoms of depression, anxiety or psychosis
Israel | |
Dept. of Ophthalmology, Shaare Zedek Medical Center | |
Jerusalem, Israel, 91031 |
Principal Investigator: | Menachem Oberbaum, M.D. | Shaare Zedek Medical Center, Jerusalem, Israel |
Study ID Numbers: | ACP GL 01 06 CTIL |
Study First Received: | March 27, 2006 |
Last Updated: | September 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00307918 History of Changes |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
acupuncture, intraocular pressure, glaucoma |
Glaucoma |